Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
International Journal of Molecular Sciences|December 30, 2015
RUCAM in Drug and Herb Induced Liver Injury: The UpdateGaby Danan, Rolf TeschkeFrontiers in Pharmacology|August 17, 2019
Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and FutureGaby Danan, Rolf TeschkeInternational Journal of Molecular Sciences|January 12, 2018
Molecular Research on Drug Induced Liver InjuryRolf Teschke, Gaby DananBritish Journal of Clinical Pharmacology|April 3, 2018
Drug induced liver injury with analysis of alternative causes as confounding variablesRolf Teschke, Gaby DananExpert Opinion on Drug Metabolism & Toxicology|November 9, 2016
Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?Rolf Teschke, Gaby DananDiagnostics (Basel, Switzerland)|April 3, 2021
Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM)Rolf Teschke, Gaby DananMedicines (Basel, Switzerland)|October 2, 2020
Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive AnalysisRolf Teschke, Gaby DananMedicines (Basel, Switzerland)|April 26, 2024
Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment MethodRolf Teschke, Gaby DananInternational Journal of Molecular Sciences|April 3, 2021
Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and ControversiesRolf Teschke, Gaby DananDrug Safety|March 5, 2018
Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?Gaby Danan, Rolf TeschkePageof 2